A new partnership between Atomwise Inc. and the prolific Silicon Valley-based seed funder Y Combinator (YC) is creating a new launch pad for academic researchers building companies around promising compounds discovered with the artificial intelligence (AI) platform Atomnet, a neural network that can help pare millions of potential molecules down to a curated subset ready for preclinical testing.